Related Experiment Video
Updated: Jul 8, 2026

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
Published on: April 4, 2022
Intracoronary nicorandil relieves multiple coronary vasospasm with hemodynamic collapse
Takaharu Hayashi1, Minoru Ichikawa, Akio Iwata
1Cardiovascular Division,Kawachi General Hospital, 1-31 Yokomakura, Higashi-osaka 578-0955, Japan. takaharu@kawati.org
Insights
This case study highlights nicorandil as an effective treatment for coronary vasospasm. The potassium-channel opener successfully relieved severe chest discomfort in a patient unresponsive to other medications.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Coronary vasospasm can cause severe chest discomfort and hemodynamic compromise.
- Standard treatments like isosorbide dinitrate and verapamil may not always be effective.
Observation:
- A patient presented with chest discomfort due to subtotal coronary artery occlusion, suspected to be vasospasm.
- Intracoronary isosorbide dinitrate and intravenous verapamil failed to alleviate symptoms.
- Intracoronary nicorandil, a potassium-channel opener, provided significant relief.
Findings:
- Nicorandil demonstrated efficacy in relieving coronary vasospasm refractory to other treatments.
- The patient experienced recurrent symptoms upon medication cessation, which were again resolved by nicorandil.
Implications:
- Nicorandil may be a valuable therapeutic option for managing refractory coronary vasospasm.
- This case underscores the importance of identifying and treating coronary vasospasm effectively to prevent adverse cardiovascular events.
Abstract:
A 49-year-old woman was referred to hospital because of chest discomfort. Coronary angiography revealed subtotal occlusion of the left coronary artery and the right coronary artery, but subsequent hemodynamic collapse occurred. Based on the results of intravascular ultrasound the occlusion was suspected to be caused by coronary vasospasm, which was not relieved by intracoronary injection of isosorbide dinitrate (1 mg), but was alleviated by nicorandil (2 mg), a potassium-channel opener. After discharge from hospital, the patient stopped taking her medication and returned complaining of chest discomfort again. Intravenous verapamil (5 mg) did not improve it, but direct intracoronary administration of nicorandil (2 mg) did bring relief. This case suggests that nicorandil is effective for coronary vasospasm.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Acute Coronary Syndrome V: Nursing Management
Angina IV: Management

